Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma

NCT03233347 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Ann Arbor Stage I Hodgkin Lymphoma
Ann Arbor Stage IA Hodgkin Lymphoma
Ann Arbor Stage IB Hodgkin Lymphoma
Ann Arbor Stage II Hodgkin Lymphoma
Ann Arbor Stage IIA Hodgkin Lymphoma
Ann Arbor Stage IIB Hodgkin Lymphoma
Classic Hodgkin Lymphoma

Interventions

DRUG: Brentuximab Vedotin
DRUG: Dacarbazine
DRUG: Doxorubicin
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Nivolumab
DRUG: Vinblastine

Sponsor

Academic and Community Cancer Research United

Collaborators

[object Object]